Xeris Pharmaceuticals, Inc.: payments to doctors
Reported under the Physician Payments Sunshine Act for Open Payments program years 2019–2025. Figures group every CMS reporting entity belonging to this corporate parent.
- Total reported
- $11.4M
- Providers paid
- 37,390
- Transactions
- 128,199
- Average per transaction
- $89
The average per transaction — $89 — is the number worth reading. A large total spread across hundreds of thousands of transactions is a company buying a great many modest meals at educational presentations. A large total across few transactions means consulting, speaking or royalty arrangements with a small number of physicians. The totals alone do not distinguish them.
Where the money went
| State | Total reported | Share |
|---|---|---|
| Arizona | $3,169,181 | 27.8% |
| California | $875,170 | 7.7% |
| Texas | $870,142 | 7.6% |
| Wisconsin | $852,101 | 7.5% |
| Florida | $714,404 | 6.3% |
| Illinois | $570,041 | 5.0% |
| New York | $564,934 | 5.0% |
| Ohio | $547,602 | 4.8% |
| Georgia | $505,822 | 4.4% |
| Tennessee | $318,209 | 2.8% |
| Pennsylvania | $291,025 | 2.6% |
| Washington | $234,022 | 2.1% |
| Maryland | $214,086 | 1.9% |
| Alabama | $169,165 | 1.5% |
| North Carolina | $135,870 | 1.2% |
| Connecticut | $130,149 | 1.1% |
| Michigan | $127,931 | 1.1% |
| New Jersey | $93,189 | 0.8% |
| South Carolina | $91,489 | 0.8% |
| Oklahoma | $82,422 | 0.7% |
| Virginia | $81,709 | 0.7% |
| Indiana | $72,212 | 0.6% |
| Massachusetts | $64,312 | 0.6% |
| Oregon | $64,267 | 0.6% |
| Kentucky | $61,774 | 0.5% |
| New Mexico | $61,125 | 0.5% |
| Missouri | $51,477 | 0.5% |
| Louisiana | $49,289 | 0.4% |
| Mississippi | $47,494 | 0.4% |
| West Virginia | $37,753 | 0.3% |
| Nevada | $30,509 | 0.3% |
| Arkansas | $25,579 | 0.2% |
| Utah | $25,177 | 0.2% |
| Kansas | $24,047 | 0.2% |
| Rhode Island | $23,992 | 0.2% |
| Nebraska | $21,874 | 0.2% |
| Colorado | $19,603 | 0.2% |
| Minnesota | $15,409 | 0.1% |
| Iowa | $14,753 | 0.1% |
| Delaware | $14,167 | 0.1% |
| Idaho | $13,484 | 0.1% |
| District of Columbia | $5,342 | 0.0% |
| New Hampshire | $2,197 | 0.0% |
| Alaska | $1,864 | 0.0% |
| Hawaii | $1,802 | 0.0% |
| North Dakota | $1,587 | 0.0% |
| Puerto Rico | $1,568 | 0.0% |
| Wyoming | $1,568 | 0.0% |
| Montana | $1,414 | 0.0% |
| Maine | $1,232 | 0.0% |
| South Dakota | $1,159 | 0.0% |
| AE | $184 | 0.0% |
| ZZ | $119 | 0.0% |
| Vermont | $66 | 0.0% |
| Guam | $65 | 0.0% |
| XX | $19 | 0.0% |
Products named in Xeris Pharmaceuticals, Inc.'s payments
The drugs and devices most often named as the product a payment related to. A meal at a presentation about a product counts here, so this tracks what the company promotes as much as what it sells.
- GVOKE HYPOPEN$2,140,728
- RECORLEV$1,321,526
- GVOKE PFS$1,205,730
- KEVEYIS$240,086